We are live on ! Find out more
STAB

Statera Biopharma, Inc. Common Stock
STAB

Delisted

STAB was delisted on the 11th of January, 2023.

Back to rankings

41 hedge funds and large institutions have $7.62M invested in Statera Biopharma, Inc. Common Stock in 2013 Q2 according to their latest regulatory filings, with 41 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

379% more call options, than puts

Call options by funds: $532K | Put options by funds: $111K

Holders
41
Holders Change
+41
Holders Change %
–
% of All Funds
1.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
41
Increased
–
Reduced
–
Closed
–
Calls
$532K
Puts
$111K
Net Calls
+$421K
Net Calls Change
+$421K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.12M +$2.31M +67,171 New
LTFS
2
Ladenburg Thalmann Financial Services
Florida
$1.17M +$1.28M +37,310 New
PGCM
3
Prescott Group Capital Management
Oklahoma
$1.1M +$1.2M +34,865 New
GIG
4
Goodnow Investment Group
Connecticut
$951K +$1.04M +30,094 New
BC
5
BHR Capital
New York
$474K +$516K +15,000 New
Jacobs Levy Equity Management
6
Jacobs Levy Equity Management
New Jersey
$254K +$277K +8,036 New
Geode Capital Management
7
Geode Capital Management
Massachusetts
$210K +$229K +6,658 New
California Public Employees Retirement System
8
California Public Employees Retirement System
California
$181K +$197K +5,715 New
BFA
9
BlackRock Fund Advisors
California
$159K +$174K +5,040 New
Northern Trust
10
Northern Trust
Illinois
$116K +$126K +3,665 New
D.E. Shaw & Co
11
D.E. Shaw & Co
New York
$113K +$123K +3,567 New
RHJA
12
Rice Hall James & Associates
California
$111K +$120K +3,499 New
OC
13
Oppenheimer & Co
New York
$77K +$83.7K +2,431 New
MIM
14
Macroview Investment Management
Maryland
$60K +$65.4K +1,900 New
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
$55K +$60.2K +1,750 New
Morgan Stanley
16
Morgan Stanley
New York
$37K +$40.8K +1,184 New
Group One Trading
17
Group One Trading
Illinois
$36K +$39.6K +1,150 New
Goldman Sachs
18
Goldman Sachs
New York
$34K +$37.1K +1,077 New
Dimensional Fund Advisors
19
Dimensional Fund Advisors
Texas
$32K +$34.4K +998 New
Neuberger Berman Group
20
Neuberger Berman Group
New York
$32K +$34.4K +1,000 New
VCAM
21
Van Cleef Asset Management
Ohio
$32K +$34.4K +1,000 New
State Street
22
State Street
Massachusetts
$31K +$33.2K +965 New
WF
23
WealthTrust Fairport
Ohio
$31K +$33.8K +983 New
GC
24
Guggenheim Capital
Illinois
$30K +$32.4K +942 New
TAM
25
Taurus Asset Management
New York
$24K +$25.8K +750 New
1
2

STAB Hedge Fund Activity: Q2 2013 in Review

41 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Statera Biopharma, Inc. Common Stock (STAB) for Q2 2013, worth a combined $7.62M.

Buyers outnumbered sellers: 41 funds opened new STAB positions and 0 closed out — a net gain of 41 holders — while 0 added to existing stakes and 0 trimmed.

  • 41 institutional investors held Statera Biopharma, Inc. Common Stock (STAB) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $7.62M of Statera Biopharma, Inc. Common Stock stock for Q2 2013.
  • 41 funds opened new Statera Biopharma, Inc. Common Stock positions in Q2 2013 and 0 closed out, a net change of +41 holders.

Based on aggregated 13F filings for Q2 2013.